ANALYTICAL VALIDATION OF A 10-COLOR FLOW CYTOMETRY PANEL FOR ASSESSMENT OF MEASURABLE RESIDUAL DISEASE OF ACUTE MYELOID LEUKEMIA

Autor: AR Severino, CM Bertolucci, JFDS Tosi, MRV Ikoma-Colturato

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S190- (2024)

The assessment of measurable residual disease (MRD) in acute myeloid leukemia (AML) by flow cytometry (FC) is challenging and requires full standardization to provide reliable results for patient management. Here is shown the analytical validation of

Externí odkaz: https://doaj.org/article/e1bd2079048b4dab8c5ae55ea513c333

DETECTION OF HEMATOPOIETIC NEOPLASMS IN CEREBROSPINAL FLUID BY IMMUNOPHENOTYPING: SINGLE-CENTER DATA ANALYSIS

Autor: GF Bevilacqua, CM Bertolucci, AR Severino, RL Teotonio, M Penitenti, JE Conti-Spilari, MRV Ikoma-Colturato

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S437-S438 (2021)

Introduction: Cerebrospinal fluid (CSF) infiltration can be identified at diagnosis and during the course of many hematopoietic malignancies, mainly acute leukemia and aggressive non-Hodgking lymphomas (NHL). The accurate diagnosis of central nervous

Externí odkaz: https://doaj.org/article/ee22d1ce7a7a44d19d76f81fb624b54b

Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia.

Autor: Pinto CM; Hospital Amaral Carvalho, Jau, São Paulo, Brazil., Bertolucci CM; Hospital Amaral Carvalho, Jau, São Paulo, Brazil., Severino AR; Hospital Amaral Carvalho, Jau, São Paulo, Brazil., Dos Santos Tosi JF; Hospital Amaral Carvalho, Jau, São Paulo, Brazil., Ikoma-Colturato MRV; Hospital Amaral Carvalho, Jau, São Paulo, Brazil; Sabin Medicina Diagnóstica, Brasilia, DF, Brazil. Electronic address: maura.ikoma@amaralcarvalho.org.br.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2024 Oct-Dec; Vol. 46 (4), pp. 542-548. Date of Electronic Publication: 2023 Nov 17.

The recombinome of IKZF1 deletions in B-cell precursor ALL.

Autor: Lopes BA; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. blopes@inca.gov.br.; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany. blopes@inca.gov.br., Meyer C; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Bouzada H; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Külp M; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Maciel ALT; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Larghero P; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Barbosa TC; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Poubel CP; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Barbieri C; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Venn NC; Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia., Pozza LD; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia., Barbaric D; Sydney Children's Hospital, Randwick, NSW, Australia., Palmi C; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Fazio G; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Saitta C; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Aguiar TF; Arthur Siqueira Cavalcanti Hematology Institute (HEMORIO), Rio de Janeiro, Brazil., Lins MM; Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil., Ikoma-Colturato MRV; Hospital Amaral Carvalho, São Paulo, Brazil., Schramm M; Prontobaby Hospital da Criança, Rio de Janeiro, Brazil.; Serviço de Hematologia, Hospital do Câncer I, INCA, Rio de Janeiro, Brazil., Chapchap E; Hospital Israelita Albert Einstein, São Paulo, Brazil., Cazzaniga G; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Medical Genetics, School of Medicine and Surgery, University of Milan Bicocca, Monza, Italy., Sutton R; Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia., Marschalek R; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Emerenciano M; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. memerenciano@inca.gov.br.

Publikováno v: Leukemia [Leukemia] 2023 Aug; Vol. 37 (8), pp. 1727-1731. Date of Electronic Publication: 2023 Jun 29.

Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels.

Autor: Beltrame MP; Hospital Erasto Gaertner, Laboratório de Citometria de Fluxo, Curitiba, PR, Brazil. Electronic address: mpbeltrame@yahoo.com.br., Souto EX; Hospital do Câncer de Barretos, Barretos, SP, Brazil; Hospital Brigadeiro, São Paulo, SP, Brazil., Yamamoto M; Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil., Furtado FM; Sabin Medicina Diagnóstica, Brasília, DF, Brazil; Hospital da Criança de Brasília José Alencar, Brasilia, DF, Brazil., da Costa ES; Instituto de Puericultura e Pediatria Margatão Gesteira, Universidade Federal do Rio de Janeiro (IPPMG/UFRJ), Rio de Janeiro, RJ, Brazil., Sandes AF; Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil; Grupo Fleury - Divisão de Hematologia e Citometria de Fluxo, São Paulo, SP, Brazil., Pimenta G; Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Cavalcanti Júnior GB; Faculdade de Farmácia, Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, Brazil., Santos-Silva MC; Universidade Federal de Santa Catarina (UFSC) - Florianópolis, SC, Brazil., Lorand-Metze I; Faculdade de Ciências Médicas, Universidade Estadual de Campinas (FCM Unicamp), Campinas, SP, Brazil., Ikoma-Colturato MRV; Sabin Medicina Diagnóstica, Brasília, DF, Brazil; Hospital Amaral Carvalho, Jaú, SP, Brazil.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2021 Oct-Dec; Vol. 43 (4), pp. 499-506. Date of Electronic Publication: 2021 May 21.